Prospect Capital Corporation announced that Prospect recently purchased $38 million of first lien senior secured floating rate notes issued by Memorial MRI & Diagnostic, L.L.C. (MMRI), a portfolio company of Baymark Partners. Based in Dallas, Texas, Baymark is a private equity firm focused on middle-market companies in the business and healthcare services industries.

Founded in 2001, MMRI is a provider of multi-modality diagnostic imaging and pain management services with six facilities operating in Houston. MMRI provides patients with a comprehensive healthcare solution, encompassing facilities and equipment, highly trained technicians, and streamlined payment processing. MMRI is certified by the American College of Radiology.

“The Prospect team demonstrated a strong knowledge of healthcare services, worked within our demanding timetable, and delivered a tailored financing solution for MMRI,” said Anthony Ludlow, Managing Director of Baymark. “We greatly enjoyed our experience working with Prospect and look forward to our next transaction with Prospect.”

“Prospect is pleased to support the growth of MMRI in the Houston and overall Texas markets,” said David Moszer, Managing Director of Prospect Capital Management L.P. “MMRI’s services in the imaging and diagnostic market provide high quality medical services in a low-cost, non-hospital setting.”